Gold prices are climbing for the fifth consecutive session. Optimism surrounding a U.S.-Iran peace deal is easing concerns about interest rate hikes. Investors are now awaiting details of the deal and the Federal Reserve’s policy meeting. Projections suggest U.S. short-term borrowing costs will remain unchanged throughout the year. Reserve managers anticipate increasing their gold holdings.
Zydus Lifesciences shares fall 2% as firm acquires US-based Assertio Holdings for $166 million
Zydus Lifesciences’ shares dipped 2% after completing the $166.4 million acquisition of US-based Assertio Holdings Inc. The deal, finalized through a subsidiary, makes Assertio a
June 17, 2026